Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Morrot, A.
Right arrow Articles by Scharfstein, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morrot, A.
Right arrow Articles by Scharfstein, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol 9, 825-834, Copyright © 1997 by Oxford University Press


ARTICLES

Human T cell responses against the major cysteine proteinase (cruzipain) of Trypanosoma cruzi: role of the multifunctional alpha 2- macroglobulin receptor in antigen presentation by monocytes

A Morrot, DK Strickland, L Higuchi M de, M Reis, R Pedrosa and J Scharfstein
Instituto de Biofisica Carlos Chagas Filho-UFRJ, Laboratorio de Imunologia Molecular, Rio de Janeiro, Brazil.

Chagas' disease patients (CDP) develop both humoral and cellular immune responses against the major cysteine proteinase (cruzipain) from Trypanosoma cruzi. Here we demonstrate that complexes formed by cruzipain and alpha 2-macroglobulin (alpha 2M) are efficiently internalized by human monocytes, and that this process results in enhanced presentation of cruzipain peptides to CD4+ T cells from CDP. Purified or serum alpha 2M binds to polymorphic cruzipains, but only a fraction of the proteinases become covalently linked. Once bound to alpha 2M, fluorescein-labeled cruzipain (FITC-cruzipain) or [125I]cruzipain were more efficiently internalized by normal peripheral blood mononuclear cells (PBMC) or monocytes; this effect was abolished by (I) pre-treating the cells with receptor-associated protein (rRAP), a known antagonist the of alpha 2M receptor (alpha 2MR/LRP), and (II) inactivating [125I]cruzipain's active site prior to the reaction with alpha 2M, indicating that the exposure of receptor binding sites on alpha 2M complexes required bait region cleavage. We then sought to determine if the alpha 2MR/LRP-dependent uptake of alpha 2M:cruzipain by monocytes resulted in increased CD4+ T cell responses of PBMC-CDP (n = 13). These effects were only revealed after depletion of CD19+ B lymphocytes from PBMC-CDP; the threshold of T cell stimulation was far lower in cultures stimulated with alpha 2M:cruzipain, as compared to antigen alone. Myocardial specimens from CDP with chronic myocardiopathy (three necropsies) were analyzed by immunohistochemistry with mAb anti-cruzipain or anti-alpha 2MR/LRP (CD81+). Extracellular depots of cruzipain were localized amidst inflammatory mononuclear infiltrates, part of which contained CD91+ macrophage-like cells. Ongoing studies should clarify if T. cruzi cysteinyl proteinases play a role in the pathogenesis of Chagas' heart disease.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Int ImmunolHome page
D. M. Acosta, M. R. Arnaiz, M. I. Esteva, M. Barboza, D. Stivale, U. D. Orlando, S. Torres, S. A. Laucella, A. S. Couto, and V. G. Duschak
Sulfates are main targets of immune responses to cruzipain and are involved in heart damage in BALB/c immunized mice
Int. Immunol., April 1, 2008; 20(4): 461 - 470.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Morgun, N. Shulzhenko, A. Perez-Diez, R. V.Z. Diniz, G. F. Sanson, D. R. Almeida, P. Matzinger, and M. Gerbase-DeLima
Molecular Profiling Improves Diagnoses of Rejection and Infection in Transplanted Organs
Circ. Res., June 23, 2006; 98(12): e74 - e83.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. P. Aoki, N. L. Guinazu, A. V. Pellegrini, T. Gotoh, D. T. Masih, and S. Gea
Cruzipain, a major Trypanosoma cruzi antigen, promotes arginase-2 expression and survival of neonatal mouse cardiomyocytes
Am J Physiol Cell Physiol, February 1, 2004; 286(2): C206 - C212.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
J. P. Hart, M. D. Gunn, and S. V. Pizzo
A CD91-Positive Subset of CD11c+ Blood Dendritic Cells: Characterization of the APC that Functions to Enhance Adaptive Immune Responses against CD91-Targeted Antigens
J. Immunol., January 1, 2004; 172(1): 70 - 78.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. C. Waghabi, C. M. L. M. Coutinho, M. N. C. Soeiro, M. C. S. Pereira, J.-J. Feige, M. Keramidas, A. Cosson, P. Minoprio, F. Van Leuven, and T. C. Araujo-Jorge
Increased Trypanosoma cruzi Invasion and Heart Fibrosis Associated with High Transforming Growth Factor {beta} Levels in Mice Deficient in {alpha}2-Macroglobulin
Infect. Immun., September 1, 2002; 70(9): 5115 - 5123.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. Scharfstein, V. Schmitz, V. Morandi, M. M. A. Capella, A. P. C. A. Lima, A. Morrot, L. Juliano, and W. Muller-Esterl
Host Cell Invasion by TRYPANOSOMA cRUZI Is Potentiated by Activation of Bradykinin B2 Receptors
J. Exp. Med., November 6, 2000; 192(9): 1289 - 1300.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
B. T. Hyman, D. Strickland, and G. W. Rebeck
Role of the Low-density Lipoprotein Receptor-Related Protein in {beta}-Amyloid Metabolism and Alzheimer Disease
Arch Neurol, May 1, 2000; 57(5): 646 - 650.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Del Nery, M. A. Juliano, A. P. C. A. Lima, J. Scharfstein, and L. Juliano
Kininogenase Activity by the Major Cysteinyl Proteinase (Cruzipain) from Trypanosoma cruzi
J. Biol. Chem., October 10, 1997; 272(41): 25713 - 25718.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.